Showing 381-390 of 2874 results for "".
- HydraFacial To Go Public After SPAC Dealhttps://modernaesthetics.com/news/hydrafacial-to-go-public-after-spac-deal/2473028/The HydraFacialCompany and Vesper Healthcare, a special purpose acquisition company (SPAC) co-founded by Brent Saunders, former CEO of Allergan, have entered into a definitive merger agreement. Under the terms of the agreement, HydraFacial and Vesper Healthcare will combine, and HydraFa
- Revance Update: FDA Defers Approval of DaxibotulinumtoxinA Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspectionhttps://modernaesthetics.com/news/revance-update-fda-defers-approval-of-daxibotulinumtoxina-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/2473027/The U.S. Food and Drug Administration (FDA) deferred a decision on the Biologics License Application (BLA) for Revance’s DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the treatment of moderate to severe glabellar lines. In a communication r
- ZO Skin Health Adds Colleen Goggins to Board of Directorshttps://modernaesthetics.com/news/zo-skin-health-adds-colleen-goggins-to-board-of-directors/2473024/Colleen Goggins is joining ZO Skin Health’s board of directors. This follows the recent acquisition of a majority stake in the business in October by funds managed by Blackstone Tactical Opportunities. As a partner and counsellor to a large variety of bu
- Demandforce Launches Online Booking Functionalityhttps://modernaesthetics.com/news/demandforce-launches-online-booking-functionality/2473020/Demandforce has launched Demandforce Online Booking, a new functionality that makes it easier for clients of Demandforce business users to schedule appointments online while enabling businesses to manage their appointment sche
- Promising Results from Dysport Dose Escalation Studyhttps://modernaesthetics.com/news/promising-results-from-dysport-dose-escalation-study/2473018/Top-line results from a Phase 2 dose escalation study show that significantly more subjects treated with Dysport® at all four doses achieved a composite two grade improvement responder rate than those treated with placebo at one month. The study accessed the duration of ef
- Aesthetics Biomedical Inaugurates Microneedling Dayhttps://modernaesthetics.com/news/aesthetics-biomedical-inaugurates-microneedling-day/2473008/It’s official! #NationalMicroneedlingDay is October 26. Aesthetics Biomedical® (ABM) says the day has been recognized by the National Day Archives as an official holiday on the National Day Registry™ to honor the leading radiofrequency microneedling treatment in th
- Suneva, Neauvia Partner to Market and Distribute Plasma IQ in North Americahttps://modernaesthetics.com/news/suneva-neauvia-partner-to-market-and-distribute-plasma-iq-in-north-america-1/2472993/Suneva Medical, Inc., will market and distribute Neauvia Plasma IQ throughout North America as part of a new partnership. The first Class 2 FDA-cleared plasma energy device, Plasma IQ delivers focused, controlled plasma energy to create microinjuries on the skin, renewing
- Allergan Aesthetics and Skinbetter Science Launch The DREAM Initiative to Advance Health Equity and Diversity in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-and-skinbetter-science-launch-the-dream-initiative-to-advance-health-equity-and-diversity-in-aesthetics/2472990/Allergan Aesthetics, an AbbVie company, and Skinbetter Science have jointly launched a new long-term, educational initiative—DREAM: Driving Racial Equity in Aesthetic Medicine. The DREAM Initiative™ is committed to furthering the principles of racial and ethnic diversity, inclus
- Consumer Products Vet Anne Gates Joins Cynosure's Board of Directorshttps://modernaesthetics.com/news/consumer-products-vet-anne-gates-joins-cynosures-board-of-directors/2472989/Anne Gates, former President at MGA Entertainment and Executive Vice President and CFO of The Walt Disney Company's Consumer Products Division, has joined Cynosure’s board of directors and will chair the company's audit committee. "Anne brings with her a wealth o
- NYC Dermatologist Dr. Doris Day Joins Nufabrx’s Ad Boardhttps://modernaesthetics.com/news/nyc-dermatologist-dr-doris-day-joins-nufabrxs-ad-board/2472988/New York City dermatologist Doris Day, MD is the newest member of Nufabrx’s advisory board. Nufabrx is an advanced textiles company that has developed a proprietary biomaterial platform that embeds active ingredient